Patrick G. Johnston

27.0k total citations · 3 hit papers
195 papers, 20.0k citations indexed

About

Patrick G. Johnston is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Patrick G. Johnston has authored 195 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Oncology, 89 papers in Molecular Biology and 47 papers in Pathology and Forensic Medicine. Recurrent topics in Patrick G. Johnston's work include Colorectal Cancer Treatments and Studies (67 papers), Genetic factors in colorectal cancer (38 papers) and Cancer-related Molecular Pathways (28 papers). Patrick G. Johnston is often cited by papers focused on Colorectal Cancer Treatments and Studies (67 papers), Genetic factors in colorectal cancer (38 papers) and Cancer-related Molecular Pathways (28 papers). Patrick G. Johnston collaborates with scholars based in United Kingdom, United States and Ireland. Patrick G. Johnston's co-authors include Daniel B. Longley, D. Paul Harkin, Sandra Van Schaeybroeck, Caitriona Holohan, Wendy L. Allen, Paul B. Mullan, David Waugh, Richard D. Kennedy, Carmen J. Allegra and Timothy R. Wilson and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Patrick G. Johnston

192 papers receiving 19.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

5-Fluorouracil: mechanisms of action and clinical strategies

2003 4.0k citations Daniel B. Longley, D. Paul Harkin et al. profile →
Cancer drug resistance: an evolving paradigm

2013 3.6k citations Caitriona Holohan, Sandra Van Schaeybroeck et al. profile →
Transcriptomic analysis of autistic brain reveals convergent molecular pathology

2011 1.3k citations Patrick G. Johnston et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick G. Johnston United Kingdom	66	10.1k	8.5k	3.6k	2.8k	2.4k	195	20.0k
Andrew K. Godwin United States	79	13.4k 1.3×	6.0k 0.7×	5.2k 1.5×	2.5k 0.9×	2.1k 0.9×	386	22.4k
Evan T. Keller United States	76	8.4k 0.8×	7.5k 0.9×	3.1k 0.9×	4.1k 1.5×	1.3k 0.5×	275	18.2k
Andres J. Klein–Szanto United States	83	12.0k 1.2×	7.0k 0.8×	4.9k 1.4×	2.6k 0.9×	1.4k 0.6×	383	21.3k
Michael S. Pepper South Africa	75	11.0k 1.1×	4.8k 0.6×	4.6k 1.3×	1.4k 0.5×	1.3k 0.6×	346	20.9k
William E. Grizzle United States	82	14.1k 1.4×	6.3k 0.7×	6.4k 1.8×	3.3k 1.2×	1.9k 0.8×	499	26.2k
Joseph R. Bertino United States	75	10.2k 1.0×	8.6k 1.0×	2.5k 0.7×	2.4k 0.9×	2.3k 0.9×	471	23.2k
C. Patrick Reynolds United States	74	12.7k 1.3×	5.0k 0.6×	4.8k 1.3×	2.2k 0.8×	1.1k 0.5×	338	21.8k
Patricia S. Steeg United States	73	13.2k 1.3×	8.4k 1.0×	4.3k 1.2×	5.2k 1.9×	3.7k 1.5×	200	23.1k
James A. McCubrey United States	79	16.1k 1.6×	6.8k 0.8×	3.9k 1.1×	1.9k 0.7×	2.1k 0.9×	421	24.9k
Hisao Ito Japan	60	12.2k 1.2×	3.8k 0.5×	1.9k 0.5×	2.6k 0.9×	1.6k 0.6×	564	21.5k

Countries citing papers authored by Patrick G. Johnston

Since Specialization

Citations

This map shows the geographic impact of Patrick G. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Johnston more than expected).

Fields of papers citing papers by Patrick G. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick G. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Johnston. The network helps show where Patrick G. Johnston may publish in the future.

Co-authorship network of co-authors of Patrick G. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick G. Johnston. A scholar is included among the top collaborators of Patrick G. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick G. Johnston. Patrick G. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Refaat, Alaa, Hajrah Khawaja, Wendy L. Allen, et al.. (2018). The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic BRAF Mutant Colorectal Cancer. Molecular Cancer Therapeutics. 17(6). 1280–1290. 19 indexed citations

Dunne, Philip D., Darragh G. McArt, Paul G. O’Reilly, et al.. (2016). Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy. Cancer Immunology Research. 4(7). 582–591. 31 indexed citations

Dunne, Philip D., Darragh G. McArt, Conor A. Bradley, et al.. (2016). Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer. Clinical Cancer Research. 22(16). 4095–4104. 103 indexed citations

Bradley, Conor A., Joanna Majkut, Catherine Higgins, et al.. (2016). FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 15(10). 2432–2441. 19 indexed citations

Dunne, Philip D., Sonali Dasgupta, Jaine K. Blayney, et al.. (2015). EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer. Clinical Cancer Research. 22(1). 230–242. 108 indexed citations

Crawford, Nyree, Lucía Pérez–Carbonell, Mark Lawler, et al.. (2015). HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF -Mutant Colorectal Cancer by Downregulation of c-FLIPL. Clinical Cancer Research. 21(14). 3230–3240. 55 indexed citations

Dunne, Philip D., Darragh G. McArt, Jaine K. Blayney, et al.. (2013). AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer. Clinical Cancer Research. 20(1). 164–175. 89 indexed citations

Allen, Wendy L., Richard Turkington, Leanne Stevenson, et al.. (2012). Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells. Molecular Cancer Therapeutics. 11(8). 1724–1734. 7 indexed citations

Stevenson, Leanne, Wendy L. Allen, Richard Turkington, et al.. (2012). Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer. Clinical Cancer Research. 18(19). 5412–5426. 49 indexed citations

10.

Buckley, Niamh E., Karin Jirström, Elaine W. Kay, et al.. (2011). The ΔNp63 Proteins Are Key Allies of BRCA1 in the Prevention of Basal-Like Breast Cancer. Cancer Research. 71(5). 1933–1944. 34 indexed citations

11.

Allen, Wendy L., Leanne Stevenson, Vicky M. Coyle, et al.. (2011). A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer. Molecular Cancer Therapeutics. 11(1). 119–131. 30 indexed citations

12.

Yuen, Hiu‐Fung, James T. Murray, Angela Platt‐Higgins, et al.. (2011). Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways. Clinical Cancer Research. 18(2). 380–391. 4 indexed citations

13.

McLornan, Donal P., Helen L. Barrett, Robert Cummins, et al.. (2010). Prognostic Significance of TRAIL Signaling Molecules in Stage II and III Colorectal Cancer. Clinical Cancer Research. 16(13). 3442–3451. 64 indexed citations

14.

Schaeybroeck, Sandra Van, Joan Kyula, Takehiko Sasazuki, et al.. (2010). Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17. Cancer Research. 71(3). 1071–1080. 39 indexed citations

15.

Kyula, Joan, et al.. (2010). Chemotherapy-Induced Activation of ADAM-17: A Novel Mechanism of Drug Resistance in Colorectal Cancer. Clinical Cancer Research. 16(13). 3378–3389. 83 indexed citations

16.

Proutski, Irina, Leanne Stevenson, Wendy L. Allen, et al.. (2009). Prostate-derived factor—a novel inhibitor of drug-induced cell death in colon cancer cells. Molecular Cancer Therapeutics. 8(9). 2566–2574. 18 indexed citations

17.

Allen, Wendy L., Vicky M. Coyle, Puthen V. Jithesh, et al.. (2008). Clinical Determinants of Response to Irinotecan-Based Therapy Derived from Cell Line Models. Clinical Cancer Research. 14(20). 6647–6655. 17 indexed citations

18.

Quinn, Jennifer E., Colin R. James, Gail E. Stewart, et al.. (2007). BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy. Clinical Cancer Research. 13(24). 7413–7420. 160 indexed citations

19.

Boyer, John, Wendy L. Allen, Estelle G. McLean, et al.. (2006). Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon Cancer. Cancer Research. 66(5). 2765–2777. 87 indexed citations

20.

Kennedy, Richard D., Julia J. Gorski, Jennifer E. Quinn, et al.. (2005). BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage–Inducible Gene. Cancer Research. 65(22). 10265–10272. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact